| Literature DB >> 35524284 |
Andrainolo Ravalihasy1,2,3, Lidia Kardaś-Słoma4, Yazdan Yazdanpanah4, Valéry Ridde5,6,7.
Abstract
BACKGROUND: Combination prevention is currently considered the best approach to combat HIV epidemic. It is based upon the combination of structural, behavioral, and biomedical interventions. Such interventions are frequently implemented in a health-promoting manner due to their aims, the approach that was adopted, and their complexity. The impact evaluation of these interventions often relies on methods inherited from the biomedical field. However, these methods have limitations and should be adapted to be relevant for these complex interventions. This systematic review aims to map the evidence-based methods used to quantify the impact of these interventions and analyze how these methods are implemented.Entities:
Keywords: Combination HIV prevention; Evidence-based impact evaluation; Health promotion; Mathematical methods; Statistical methods; Study design
Mesh:
Year: 2022 PMID: 35524284 PMCID: PMC9077925 DOI: 10.1186/s13643-022-01970-z
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Search strategy
| Databases | Search terms |
|---|---|
i) TS=(HIV OR "HIV infection" OR "human immunodeficiency virus") AND TS=(prevalence OR incidence) | |
ii) AND TS=(effect OR effects OR efficacy OR effectiveness OR impact*) AND TS=(intervention* OR program* OR project OR trial*) | |
iii) AND TS=(prevention OR prophylaxis OR "primary prevention") AND TS=("unsafe sex" OR "safe sex" OR "sex work" OR "sex worker" OR "sex workers" OR "unprotected sex" OR "protected sex" OR "high-risk sex" OR "high risk sex" OR "sexual risk") | |
iv) AND LA=(English OR French) | |
v) NOT DT=("RETRACTED PUBLICATION" OR BOOK OR "book chapter" OR "PROCEEDINGS PAPER" OR "MEETING ABSTRACT") | |
i) (HIV [Title/Abstract] OR "HIV infection"[Title/Abstract] OR "human immunodeficiency virus"[Title/Abstract]) AND (prevalence[Title/Abstract] OR incidence[Title/Abstract]) | |
ii) AND (effect [Title/Abstract] OR effects [Title/Abstract] OR efficacy [Title/Abstract] OR effectiveness [Title/Abstract] OR impact*[Title/Abstract]) AND (intervention*[Title/Abstract] OR program*[Title/Abstract] OR project[Title/Abstract] OR trial*[Title/Abstract]) | |
iii) AND (prevention [Title/Abstract] OR prophylaxis[Title/Abstract] OR "primary prevention"[MeSH]) AND ("unsafe sex"[MeSH] OR "safe sex"[MeSH] OR "sex work"[MeSH] OR "unprotected sex"[Title/Abstract] OR "protected sex"[Title/Abstract] OR "sexual risk"[Title/Abstract] OR "high-risk sex"[Title/Abstract] OR "high risk sex"[Title/Abstract]) | |
iv) AND (english[Filter] OR french[Filter]) | |
v) NOT (booksdocs[Filter] OR congress[Filter] OR retractedpublication[Filter]) | |
i) TITLE-ABS-KEY(hiv OR "HIV infection" OR "human immunodeficiency virus") AND TITLE-ABS-KEY (prevalence OR incidence) | |
ii) AND TITLE-ABS-KEY(effect OR effects OR efficacy OR effectiveness OR impact*) AND TITLE-ABS-KEY (intervention* OR program* OR project OR trial*) | |
iii) AND TITLE-ABS-KEY ( prevention OR prophylaxis OR "primary prevention") AND TITLE-ABS-KEY("unsafe sex" OR "safe sex" OR "sex work" OR "sex worker" OR "sex workers" OR "unprotected sex" OR "protected sex" OR "high-risk sex" OR "high risk sex" OR "sexual risk") | |
iv) AND (LIMIT-TO (LANGUAGE, "English") OR LIMIT-TO (LANGUAGE, "French")) | |
v) AND (EXCLUDE(DOCTYPE, "tb") OR EXCLUDE(DOCTYPE, "ch") OR EXCLUDE(DOCTYPE, "cp") |
Quality assessment grid
| Section | Items |
|---|---|
| Is randomization appropriately performed? | |
| Are the groups comparable at baseline? | |
| Are there complete outcome data? | |
| Are outcome assessors blinded to the intervention provided? | |
| Did the participants adhere to the assigned intervention? | |
| Are the participants representative of the target population? | |
| Are measurements appropriate regarding both the outcome and intervention (or exposure)? | |
| Are there complete outcome data? | |
| Are the confounders accounted for in the design and analysis? | |
| During the study period, is the intervention administered (or exposure occurred) as intended? | |
| Is the minimum difference considered important to prove the intervention efficacy/effectiveness reported? | |
| Are the alpha and beta levels that define statistical significance reported and respected? | |
| What is the statistical method used to assess the intervention impact on the primary outcome? | |
| What is statistical the method used to assess the intervention impact on HIV prevalence/incidence? | |
| Did the authors report analyses to confirm that the statistical assumptions of the analysis were met or the goodness of fit of the model? | |
| Did the authors report a measure of precision alongside the impact measure? | |
| Is the design taken into account in the statistical analyses? | |
| Are the parameters to be estimated in the model specified? | |
| Are the uncertainties concerning these parameters evaluated? | |
| Are the different components of the model and their roles clearly defined? | |
| Are the different scenarios/processes/assumptions tested by the model clearly specified? | |
| Are the data and data sources specified? | |
| Are the states of the various model components clearly specified from data? | |
| Are the methods used to compute estimates specified? |